Acorda Therapeutics, Inc. Gains 18.29%
Thu, Jun 17, 2021 at 05:33 PM
Acorda Therapeutics, Inc. (ACOR:NASDAQ) shot up at $4.85, representing a gain of 18.3%. On Wed, Jun 16, 2021, ACOR:NASDAQ touched a New 2-Week Intraday High of $4.25. From Wed, Jun 02, 2021, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Wed, Jan 20, 2021 at $8.66 with a volume of 1M+, and its share price has been moving sideways in recent weeks.
About Acorda Therapeutics, Inc. (ACOR:NASDAQ)
Acorda Therapeutics Inc is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of neurological disorders.
Top 10 Gainers:
- Midatech Pharma plc (MTP:NASDAQ), 44.61%
- 9F Inc. (JFU:NASDAQ), 27.35%
- Cellect Biotechnology Ltd. (APOP:NASDAQ), 26.91%
- Entera Bio Ltd. (ENTX:NASDAQ), 24.76%
- KNBE (KNBE:NASDAQ), 24.69%
- PTPI (PTPI:NASDAQ), 18.39%
- Acorda Therapeutics, Inc. (ACOR:NASDAQ), 18.29%
- GRAY (GRAY:NASDAQ), 17.86%
- Anterix Inc. (ATEX:NASDAQ), 17.35%
- ISUN (ISUN:NASDAQ), 16.65%